Developer docs
API playgroundTry for free, no card

Search company profiles

Real World Data

Full company profile

uuid000ug2j

Namestring
Real World Data
Legal namestring
リアルワールドデータ株式会社 (Real World Data Co., Ltd.)
Websiteurl
rwdata.co.jp
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Real World Data Co., Ltd. (リアルワールドデータ株式会社) is a Japanese healthcare data technology company founded in 2015 by Kyoto University pharmacoepidemiology faculty and operating as a subsidiary of JMDC Inc. since July 2022. The company builds and operates Japan's largest-scale electronic medical record (EMR)-derived medical database, covering 24.4 million real patients across more than 100 healthcare institutions, and uniquely integrates this with school health checkup and infant health checkup data from 162 municipalities to create a longitudinal life course database. RWD monetizes this data through two core product lines: TidyMed, an on-premises clinical trial support system for hospitals that digitizes paper-based workflows via CTMS, eWorkSheet, and eSource EHR modules integrating directly with hospital EMR systems; and HYBPMS (Hybrid PMS), a post-marketing surveillance methodology that combines DPC, EMR, and receipt data with cloud-based additional data collection, reducing physician data entry burden by approximately 80% versus traditional usage outcome surveys.

The business model spans three revenue streams: enterprise fees from pharmaceutical companies for HYBPMS protocol design, database construction, data collection management, analysis, and publication support; TidyMed service fees paid by pharmaceutical sponsors on behalf of healthcare institutions (which receive the software at no cost); and database access/licensing fees paid by academic institutions, universities, and government/municipalities for epidemiological research and public health planning. RWD operates a sales-led GTM with direct field sales to pharmaceutical companies and direct hospital engagement, augmented by JMDC Group distribution reach (50+ pharma companies, 220+ medical institutions). The company holds ISO/IEC 27001 certification (JQA-IM1377, March 2016) and operates Computerized System Validation (CSV)-compliant on-premises deployments to meet Japanese healthcare data residency and pharmaceutical quality requirements.

RWD's strategic positioning is anchored by a flagship HYBPMS deployment with Eisai (Fycompa, which received PMDA Category 1 re-examination approval in June 2025), a 2025 partnership with Tokushukai Medical Group covering 84 institutions, an Aetion partnership for global RWE platform distribution, and a small but credentialed leadership team of physicians and clinical researchers. Strategic headquarters relocations — culminating in a May 2026 move to Minato-ku, Tokyo — and active hiring for PMS Implementation Lead and Infrastructure Engineer roles signal operational scaling consistent with the company's pipeline expansion.

Short descriptiontext

Real World Data is a Japanese healthcare data technology company that operates Japan's largest EMR-derived medical database (24.4M patients) and sells TidyMed (clinical trial support software) and HYBPMS (hybrid post-marketing survey methodology) to pharmaceutical companies and healthcare institutions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKyoto, Japan
HQ citystring
Kyoto
HQ countrystring
Japan
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
real-world evidence, clinical trial support, post-marketing surveillance, electronic medical records, medical data analytics
Industry5 codes
PRIMARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAH
Record Locator Services (RLS) & Longitudinal Record Aggregation
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLAJAJAK
Healthcare Utilization, Claims & Administrative Data Analytics
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics
NAICS code1 code
  • Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services518210
SIC code2 codes
  • Services-Computer Programming, Data Processing, Etc.7370
  • Services-Health Services8000
Product category
Healthcare Real-World Evidence and Clinical Trial Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Database Utilization Services
TypeData Monetisation
Description

RWD collects, anonymizes, and provides medical/health information databases (electronic medical records, DPC data, receipt data) to academic institutions, pharmaceutical companies, and researchers. Revenue is generated through database access fees, data provision fees, and research project collaborations. The company supports HCEI (Health, Medical, and Educational Information Evaluation Organization) in database administration, data utilization review committee operations, and system standardization.

rwdata.co.jp
2HYBPMS Post-Marketing Survey Services
TypeProfessional Services
Description

RWD provides HYBPMS services to pharmaceutical companies, conducting hybrid post-marketing database surveys that combine existing medical data with additional prospective data collection. Revenue is generated through project-based fees for survey design, protocol creation, database construction, data collection management, analysis, and publication support. RWD also earns referral fees by introducing PMS projects to healthcare institutions.

rwdata.co.jp
3TidyMed Clinical Trial Support Software
TypeSubscription Recurring
Description

TidyMed is provided to healthcare institutions (clinical research centers, trial management offices) as an on-premises electronic medical record department system. RWD appears to provide this to healthcare institutions, with costs covered by pharmaceutical companies or as part of service agreements. The system enables clinical trial workflow digitalization, generating revenue through deployment and ongoing support.

rwdata.co.jp
4Collaborative Research and Analysis
TypeProfessional Services
Description

RWD conducts joint research projects with healthcare institutions and pharmaceutical companies, providing data analysis, epidemiological research support, and publication services. Revenue is generated through research collaboration agreements, data analysis contracts, and consulting fees.

rwdata.co.jp
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Pricing details2 tiers
1TidyMed is provided to healthcare institutions at no cost, with pharmaceutical companies bearing the service fees as part of clinical trial support arrangements.
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Healthcare institutions incur no implementation or operational costs for TidyMed. The company proposes TidyMed to pharmaceutical companies, with pharmaceutical companies compensating RWD for the service.

rwdata.co.jp
2HYBPMS is offered at reduced total cost compared to traditional post-marketing surveys, with savings in monitoring management and operational costs for pharmaceutical companies.
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Facility contracts through data set creation are handled by RWD, reducing total costs for pharmaceutical companies. May also reduce periodic safety reporting requirements as a post-marketing database survey.

rwdata.co.jp
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Real World Data Co., Ltd. operates one of Japan's largest-scale electronic medical record-derived medical information databases, covering over 24.4 million real patients from 100+ healthcare institutions, and sells two core products: TidyMed®, a clinical trial support application for hospitals that digitizes workflows (eWorksheets, eSource EHR integration, CTMS, electronic signatures); and HYBPMS®, a hybrid post-marketing database survey service combining existing DPC, EMR, and receipt data with prospective cloud-based collection to reduce physician data entry burden by approximately 80% versus traditional usage outcome surveys.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • HYBPMS reduces physician data entry burden by approximately 80% compared to traditional usage outcome surveys, according to RWD's own research
+2 more records
Product overview1 text field

Real World Data Co., Ltd. operates as a healthcare data technology company with two primary business segments: Medical Institution Support Services and Clinical Development/PMS Support Services. The company's core product portfolio centers on TidyMed® (electronic medical record-integrated clinical trial support system) and HYBPMS® (additional data collection-type post-marketing database survey), supported by a large-scale electronic medical record-derived database. TidyMed provides a suite of clinical trial support modules including eWorkSheet, eSource EHR, and CTMS; HYBPMS provides post-marketing survey services combining DPC/EMR data with supplementary data collection. The products work together to address clinical trial efficiency and post-marketing survey burden reduction for medical institutions and pharmaceutical companies.

Product and service3 records
1TidyMed®
CategoryClinical Trial Management Software
Description

Clinical trial and clinical research support application for medical institutions that integrates with electronic medical record systems. Provides eWorkSheet, eSource EHR integration, CTMS, patient screening, electronic signatures, and EDC data import functionality to digitize paper-based clinical trial workflows and reduce data entry burden on medical staff.

2HYBPMS®
CategoryPost-Marketing Surveillance Service
Description

Additional data collection-type post-marketing database survey service combining DPC data, electronic medical record data, and receipt data with cloud-based supplementary data collection. Reduces physician data entry workload by approximately 80% by leveraging existing medical data for medical history, comorbidities, and concomitant medications, collecting only outcomes and adverse event data not present in existing databases.

3RWD Database (Electronic Medical Record-Derived Database)
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2025-09-16
Description

Business partnership for conducting HYBPMS post-marketing database surveys across the Tokushukai medical group. The partnership enables rapid expansion to 84 Tokushukai facilities (77 with EMR, 51 DPC facilities), providing broad geographic coverage for HYBPMS surveys. Tokushukai is Japan's largest medical group, making this partnership critical for scaling HYBPMS nationwide.

Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2025-09-16
Description

TIS provides centralized data management for Tokushukai's electronic medical record systems. Through the partnership, RWD gains access to reliably managed data from Tokushukai facilities, enabling consistent HYBPMS operations across the medical group's 84 institutions.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-10-07
Description

Joint research partnership between Kurashiki Central Hospital and JMDC Group to use electronic medical record databases for generating evidence supporting pediatric off-label drug public knowledge applications (公知申請). As part of JMDC's 'Big Data For Children' project, the collaboration aims to generate evidence for Plaquenil (プラケニル) pediatric use in Japan. Kurashiki Central Hospital is also the first to deploy TidyMed with eWorkSheet and eSource EHR features.

4Eisai Co., Ltd. (エーザイ株式会社)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-07-25
Description

Eisai collaborated with RWD on Japan's first additional data collection-type post-marketing database survey (HYBPMS) for Fycompa (フィコンパ). This pioneering HYBPMS methodology combined existing electronic medical record, receipt, and DPC data with prospective additional data collection, enabling a post-marketing survey that would not have been possible with traditional methods. Eisai's Fycompa subsequently received PMDA Category 1 re-examination approval in June 2025, validating the HYBPMS approach.

rwdata.co.jp
5JMDC (株式会社JMDC)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-07-12
Description

JMDC acquired shares in RWD, making it a JMDC group subsidiary. This capital and business partnership enables RWD to leverage JMDC's established network of 50+ pharmaceutical companies and 220+ medical institutions/academia. JMDC is a healthcare big data pioneer with 1.25 billion+ receipt records and 62 million+ health checkup records. The partnership combines RWD's electronic medical record database (24.4 million patients) with JMDC's data assets and market reach.

rwdata.co.jp
Strategic tierFlagshipTypeTechnology or IntegrationAnnounced on2022-05-10
Description

First-in-Japan partnership for joint promotion of real-world evidence services. Aetion provides a global real-world evidence platform used in international clinical development. RWD provides its electronic medical record database (24.4 million patients as of March 2022) for use on Aetion's platform, enabling Japanese healthcare data to contribute to global drug development. RWD and Aetion jointly respond to pharmaceutical company requests for RWD data utilization on the Aetion platform.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Oncology-focused real-world data company aggregating EMR data for cancer research, drug development, and post-marketing studies, serving pharma and regulators. Directly comparable to RWD's RWD platform and post-marketing surveillance offering, specialized by therapeutic area.

TypeEmerging player
Description

International real-world data and patient identification platform connecting hospital EMRs to pharma for clinical trial feasibility and RWE. Comparable to RWD's hospital-network-based RWD and clinical trial support business but at earlier stage and focused on emerging markets.

TypeBroad incumbent
Description

Global leader in clinical research services, real-world evidence, and healthcare data analytics serving pharmaceutical companies across the full drug development lifecycle. Comparable to RWD in PMS and clinical trial data services but with a much broader portfolio and global scale.

TypeDirect peer
Description

Japan-focused healthcare data company specializing in DPC and EMR-derived real-world databases, serving pharma companies for post-marketing surveillance, clinical research, and academic studies. Direct peer to RWD with overlapping Japan RWD/PMS use cases, similar customer base, and competing data assets.

TypeDirect peer
Description

Industry-leading clinical trial technology platform providing EDC, eCOA, CTMS, and eSource solutions for pharma-sponsored and investigator-initiated trials. Directly comparable to RWD's TidyMed clinical trial support system and eSource EHR integration functionality.

TypeDirect peer
Description

RWE analytics platform used by pharma and regulators to evaluate real-world data for drug effectiveness and safety decisions; RWD is a First-in-Japan data partner. Highly comparable in RWE service offering, methodology, and pharmaceutical customer base.

7JMDC Inc.
TypeBroad incumbent
Description

Parent company of RWD and Japan's largest claims-and-checkup healthcare data company (1.25B+ receipt records, 62M+ health checkup records). Highly comparable in that it operates the same Japan-centric RWD/data platform business, and is RWD's direct upstream data and distribution parent, making it the closest reference point for RWD's market position.

TypeBroad incumbent
Description

Healthcare data and analytics platform providing data warehousing, quality measurement, and population health analytics to health systems and life sciences companies. Comparable to RWD in EMR-derived data infrastructure and hospital customer base, though more focused on US provider analytics.

TypeDirect peer
Description

Global real-world data and evidence platform connecting healthcare organizations and pharma for clinical trial feasibility, cohort discovery, and RWE generation. Directly comparable to RWD's database and post-marketing surveillance business model, scaled to a global network.

TypeBroad incumbent
Description

Japan-headquartered global healthcare platform operating MR-kun, clinical trial services, and medical data businesses, including drug database and physician network services. Comparable to RWD in serving Japanese pharma with data-driven clinical development and post-marketing offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Real World Data

Healthcare Real-World Evidence and Clinical Trial Softwarerwdata.co.jp

Real World Data is a Japanese healthcare data technology company that operates Japan's largest EMR-derived medical database (24.4M patients) and sells TidyMed (clinical trial support software) and HYBPMS (hybrid post-marketing survey methodology) to pharmaceutical companies and healthcare institutions.

What Real World Data does

Real World Data Co., Ltd. (リアルワールドデータ株式会社) is a Japanese healthcare data technology company founded in 2015 by Kyoto University pharmacoepidemiology faculty and operating as a subsidiary of JMDC Inc. since July 2022. The company builds and operates Japan's largest-scale electronic medical record (EMR)-derived medical database, covering 24.4 million real patients across more than 100 healthcare institutions, and uniquely integrates this with school health checkup and infant health checkup data from 162 municipalities to create a longitudinal life course database. RWD monetizes this data through two core product lines: TidyMed, an on-premises clinical trial support system for hospitals that digitizes paper-based workflows via CTMS, eWorkSheet, and eSource EHR modules integrating directly with hospital EMR systems; and HYBPMS (Hybrid PMS), a post-marketing surveillance methodology that combines DPC, EMR, and receipt data with cloud-based additional data collection, reducing physician data entry burden by approximately 80% versus traditional usage outcome surveys.

The business model spans three revenue streams: enterprise fees from pharmaceutical companies for HYBPMS protocol design, database construction, data collection management, analysis, and publication support; TidyMed service fees paid by pharmaceutical sponsors on behalf of healthcare institutions (which receive the software at no cost); and database access/licensing fees paid by academic institutions, universities, and government/municipalities for epidemiological research and public health planning. RWD operates a sales-led GTM with direct field sales to pharmaceutical companies and direct hospital engagement, augmented by JMDC Group distribution reach (50+ pharma companies, 220+ medical institutions). The company holds ISO/IEC 27001 certification (JQA-IM1377, March 2016) and operates Computerized System Validation (CSV)-compliant on-premises deployments to meet Japanese healthcare data residency and pharmaceutical quality requirements.

RWD's strategic positioning is anchored by a flagship HYBPMS deployment with Eisai (Fycompa, which received PMDA Category 1 re-examination approval in June 2025), a 2025 partnership with Tokushukai Medical Group covering 84 institutions, an Aetion partnership for global RWE platform distribution, and a small but credentialed leadership team of physicians and clinical researchers. Strategic headquarters relocations — culminating in a May 2026 move to Minato-ku, Tokyo — and active hiring for PMS Implementation Lead and Infrastructure Engineer roles signal operational scaling consistent with the company's pipeline expansion.

Real World Data firmographics

Firmographics
Name
Real World Data
Legal name
リアルワールドデータ株式会社 (Real World Data Co., Ltd.)
Website
https://rwdata.co.jp
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
Real World Data is a Japanese healthcare data technology company that operates Japan's largest EMR-derived medical database (24.4M patients) and sells TidyMed (clinical trial support software) and HYBPMS (hybrid post-marketing survey methodology) to pharmaceutical companies and healthcare institutions.
Ownership category
akta.pro rank

Real World Data industry classification

Industry
Product category
Healthcare Real-World Evidence and Clinical Trial Software
NAICS
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (518210)
SIC
Services-Computer Programming, Data Processing, Etc. (7370), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACAIAK
De-identification, Tokenization & Privacy-Preserving Data Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLACABAH
Record Locator Services (RLS) & Longitudinal Record Aggregation
Healthcare & Life Sciences/Digital Health & Health IT/Health Information Exchange (HIE) & Interoperability
SECONDARYHLACAIAF
Healthcare Terminology, Ontology & Code Set Management (SNOMED/LOINC/ICD/RxNorm)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
SECONDARYHLAJAJAK
Healthcare Utilization, Claims & Administrative Data Analytics
Healthcare & Life Sciences/Public Health, Government & Regulators/Health Statistics, Vital Records & Population Health Analytics

Keywords

  • Real-world evidence
  • Clinical trial support
  • Post-marketing surveillance
  • Electronic medical records
  • Medical data analytics

Where Real World Data is headquartered

Location

Headquarters

HQ city
Kyoto
HQ country
Japan
HQ region
Asia

Offices2 records

Markets served

Real World Data business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Medical Database Utilization Services: RWD collects, anonymizes, and provides medical/health information databases (electronic medical records, DPC data, receipt data) to academic institutions, pharmaceutical companies, and researchers. Revenue is generated through database access fees, data provision fees, and research project collaborations. The company supports HCEI (Health, Medical, and Educational Information Evaluation Organization) in database administration, data utilization review committee operations, and system standardization.
  2. HYBPMS Post-Marketing Survey Services: RWD provides HYBPMS services to pharmaceutical companies, conducting hybrid post-marketing database surveys that combine existing medical data with additional prospective data collection. Revenue is generated through project-based fees for survey design, protocol creation, database construction, data collection management, analysis, and publication support. RWD also earns referral fees by introducing PMS projects to healthcare institutions.
  3. TidyMed Clinical Trial Support Software: TidyMed is provided to healthcare institutions (clinical research centers, trial management offices) as an on-premises electronic medical record department system. RWD appears to provide this to healthcare institutions, with costs covered by pharmaceutical companies or as part of service agreements. The system enables clinical trial workflow digitalization, generating revenue through deployment and ongoing support.
  4. Collaborative Research and Analysis: RWD conducts joint research projects with healthcare institutions and pharmaceutical companies, providing data analysis, epidemiological research support, and publication services. Revenue is generated through research collaboration agreements, data analysis contracts, and consulting fees.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractTidyMed is provided to healthcare institutions at no cost, with pharmaceutical companies bearing the service fees as part of clinical trial support arrangements.
Outcome Based/ PerformanceMulti-year contractHYBPMS is offered at reduced total cost compared to traditional post-marketing surveys, with savings in monitoring management and operational costs for pharmaceutical companies.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Real World Data product offering

Product offering

Core offering

Real World Data Co., Ltd. operates one of Japan's largest-scale electronic medical record-derived medical information databases, covering over 24.4 million real patients from 100+ healthcare institutions, and sells two core products: TidyMed®, a clinical trial support application for hospitals that digitizes workflows (eWorksheets, eSource EHR integration, CTMS, electronic signatures); and HYBPMS®, a hybrid post-marketing database survey service combining existing DPC, EMR, and receipt data with prospective cloud-based collection to reduce physician data entry burden by approximately 80% versus traditional usage outcome surveys.

Product overview

Real World Data Co., Ltd. operates as a healthcare data technology company with two primary business segments: Medical Institution Support Services and Clinical Development/PMS Support Services. The company's core product portfolio centers on TidyMed® (electronic medical record-integrated clinical trial support system) and HYBPMS® (additional data collection-type post-marketing database survey), supported by a large-scale electronic medical record-derived database. TidyMed provides a suite of clinical trial support modules including eWorkSheet, eSource EHR, and CTMS; HYBPMS provides post-marketing survey services combining DPC/EMR data with supplementary data collection. The products work together to address clinical trial efficiency and post-marketing survey burden reduction for medical institutions and pharmaceutical companies.

Differentiator

Problem solved

Functional benefit

Products and services

  • TidyMed® Clinical trial and clinical research support application for medical institutions that integrates with electronic medical record systems. Provides eWorkSheet, eSource EHR integration, CTMS, patient screening, electronic signatures, and EDC data import functionality to digitize paper-based clinical trial workflows and reduce data entry burden on medical staff.
  • HYBPMS® Additional data collection-type post-marketing database survey service combining DPC data, electronic medical record data, and receipt data with cloud-based supplementary data collection. Reduces physician data entry workload by approximately 80% by leveraging existing medical data for medical history, comorbidities, and concomitant medications, collecting only outcomes and adverse event data not present in existing databases.
  • RWD Database (Electronic Medical Record-Derived Database)

Quantifiable outcome

  • HYBPMS reduces physician data entry burden by approximately 80% compared to traditional usage outcome surveys, according to RWD's own research
  • +2 more outcomes

Companies that use Real World Data

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Real World Data technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature5 records

Real World Data partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship and core.

  • Tokushukai Medical Group (徳洲会)flagshipStrategic or Co-development Partner · 16 September 2025Business partnership for conducting HYBPMS post-marketing database surveys across the Tokushukai medical group. The partnership enables rapid expansion to 84 Tokushukai facilities (77 with EMR, 51 DPC facilities), providing broad geographic coverage for HYBPMS surveys. Tokushukai is Japan's largest medical group, making this partnership critical for scaling HYBPMS nationwide.
  • Tokushukai Information System (徳洲会インフォメーションシステム/TIS)flagshipTechnology or Integration · 16 September 2025TIS provides centralized data management for Tokushukai's electronic medical record systems. Through the partnership, RWD gains access to reliably managed data from Tokushukai facilities, enabling consistent HYBPMS operations across the medical group's 84 institutions.
  • Kurashiki Central Hospital (倉敷中央病院)flagshipStrategic or Co-development Partner · 7 October 2024Joint research partnership between Kurashiki Central Hospital and JMDC Group to use electronic medical record databases for generating evidence supporting pediatric off-label drug public knowledge applications (公知申請). As part of JMDC's 'Big Data For Children' project, the collaboration aims to generate evidence for Plaquenil (プラケニル) pediatric use in Japan. Kurashiki Central Hospital is also the first to deploy TidyMed with eWorkSheet and eSource EHR features.
  • Eisai Co., Ltd. (エーザイ株式会社)flagshipStrategic or Co-development Partner · 25 July 2024Eisai collaborated with RWD on Japan's first additional data collection-type post-marketing database survey (HYBPMS) for Fycompa (フィコンパ). This pioneering HYBPMS methodology combined existing electronic medical record, receipt, and DPC data with prospective additional data collection, enabling a post-marketing survey that would not have been possible with traditional methods. Eisai's Fycompa subsequently received PMDA Category 1 re-examination approval in June 2025, validating the HYBPMS approach.
  • JMDC (株式会社JMDC)coreStrategic or Co-development Partner · 12 July 2022JMDC acquired shares in RWD, making it a JMDC group subsidiary. This capital and business partnership enables RWD to leverage JMDC's established network of 50+ pharmaceutical companies and 220+ medical institutions/academia. JMDC is a healthcare big data pioneer with 1.25 billion+ receipt records and 62 million+ health checkup records. The partnership combines RWD's electronic medical record database (24.4 million patients) with JMDC's data assets and market reach.
  • Aetion, Inc. (エイティオン)flagshipTechnology or Integration · 10 May 2022First-in-Japan partnership for joint promotion of real-world evidence services. Aetion provides a global real-world evidence platform used in international clinical development. RWD provides its electronic medical record database (24.4 million patients as of March 2022) for use on Aetion's platform, enabling Japanese healthcare data to contribute to global drug development. RWD and Aetion jointly respond to pharmaceutical company requests for RWD data utilization on the Aetion platform.

Scale indicators9 records

Recent moves8 records

Expansion highlights5 records

Real World Data competitors and assessment

Company assessment

Direct peers

  • Flatiron Health: Oncology-focused real-world data company aggregating EMR data for cancer research, drug development, and post-marketing studies, serving pharma and regulators. Directly comparable to RWD's RWD platform and post-marketing surveillance offering, specialized by therapeutic area.
  • Medical Data Vision Co., Ltd. Japan-focused healthcare data company specializing in DPC and EMR-derived real-world databases, serving pharma companies for post-marketing surveillance, clinical research, and academic studies. Direct peer to RWD with overlapping Japan RWD/PMS use cases, similar customer base, and competing data assets.
  • Medidata Solutions (Dassault Systèmes): Industry-leading clinical trial technology platform providing EDC, eCOA, CTMS, and eSource solutions for pharma-sponsored and investigator-initiated trials. Directly comparable to RWD's TidyMed clinical trial support system and eSource EHR integration functionality.
  • Aetion, Inc. RWE analytics platform used by pharma and regulators to evaluate real-world data for drug effectiveness and safety decisions; RWD is a First-in-Japan data partner. Highly comparable in RWE service offering, methodology, and pharmaceutical customer base.
  • TriNetX, Inc. Global real-world data and evidence platform connecting healthcare organizations and pharma for clinical trial feasibility, cohort discovery, and RWE generation. Directly comparable to RWD's database and post-marketing surveillance business model, scaled to a global network.

Emerging players

  • Clinerion Ltd. International real-world data and patient identification platform connecting hospital EMRs to pharma for clinical trial feasibility and RWE. Comparable to RWD's hospital-network-based RWD and clinical trial support business but at earlier stage and focused on emerging markets.

Broad incumbents

  • IQVIA Holdings Inc. Global leader in clinical research services, real-world evidence, and healthcare data analytics serving pharmaceutical companies across the full drug development lifecycle. Comparable to RWD in PMS and clinical trial data services but with a much broader portfolio and global scale.
  • JMDC Inc. Parent company of RWD and Japan's largest claims-and-checkup healthcare data company (1.25B+ receipt records, 62M+ health checkup records). Highly comparable in that it operates the same Japan-centric RWD/data platform business, and is RWD's direct upstream data and distribution parent, making it the closest reference point for RWD's market position.
  • Health Catalyst, Inc. Healthcare data and analytics platform providing data warehousing, quality measurement, and population health analytics to health systems and life sciences companies. Comparable to RWD in EMR-derived data infrastructure and hospital customer base, though more focused on US provider analytics.
  • M3, Inc. Japan-headquartered global healthcare platform operating MR-kun, clinical trial services, and medical data businesses, including drug database and physician network services. Comparable to RWD in serving Japanese pharma with data-driven clinical development and post-marketing offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Real World Data social profiles

Digital presence

Real World Data compliance and trust

Trust signal

Compliance3 records

Real World Data financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Real World Data leadership team

Management profile

Number of profiles

Profiles1 record

Real World Data funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Real World Data M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Real World Data

What does Real World Data do?

Real World Data Co., Ltd. operates one of Japan's largest-scale electronic medical record-derived medical information databases, covering over 24.4 million real patients from 100+ healthcare institutions, and sells two core products: TidyMed®, a clinical trial support application for hospitals that digitizes workflows (eWorksheets, eSource EHR integration, CTMS, electronic signatures); and HYBPMS®, a hybrid post-marketing database survey service combining existing DPC, EMR, and receipt data with prospective cloud-based collection to reduce physician data entry burden by approximately 80% versus traditional usage outcome surveys.

Is Real World Data a public or private company?

Real World Data is a private company. It is classified as corporate owned and is currently operating.

When was Real World Data founded?

Real World Data was founded in 2015. It employs 1 to 10 people.

Where is Real World Data based?

Real World Data is headquartered in Kyoto, Japan, in the Asia region.

How does Real World Data make money?

Four revenue lines are on record. Medical Database Utilization Services are the primary driver. The others are HYBPMS Post-Marketing Survey Services, tidyMed Clinical Trial Support Software and collaborative Research and Analysis.

Who are Real World Data's main competitors?

Direct peers on record are Flatiron Health, Medical Data Vision Co., Ltd., Medidata Solutions (Dassault Systèmes), Aetion, Inc. and TriNetX, Inc.. Clinerion Ltd. is listed as an emerging player. Broad incumbents are IQVIA Holdings Inc., JMDC Inc., Health Catalyst, Inc. and M3, Inc..

Does Real World Data have an API?

No public API is recorded for Real World Data.

What industry is Real World Data in?

Real World Data's product category is Healthcare Real-World Evidence and Clinical Trial Software. Its primary akta.pro industry code is HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation, with a secondary code of HLACAIAK, De-identification, Tokenization & Privacy-Preserving Data Platforms. Its NAICS code is 518210 and its SIC code is 7370.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales